Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 2, 1996, Pages 153-160

  Drouin, Michel ^a,g   Yang, William H ^a   Bertrand, Bernard ^b   Van Cauwenberge, Paul ^c   Clement, Peter ^d   Dalby, Kjell ^e   Darnell, Royce ^f   Ernst, Thomas Matthias ^g   Hébert, Jacques ^h   Karlsson, Göran ⁱ   Luciuk, George ^g   Mazza, Jorge ^j   Roovers, Mattheus ^k   Ruoppi, Pirkko ^l   Seppey, Michel ^m   Stern, Martin ⁿ   Suonpää, Jouko ^o   Sussman, Gordon ^g   Tan, K Y ^p   Tse, Kam ^q   Widjaja, Prabowo ^r   Jensen, Peder ^s   Nolop, Keith ^s   Lutsky, Barry N ^s   more..

^a Allergy and Asthma Research Centre   (Canada)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^e Drøbak ENT Clinic   (Norway)

^f Midlands Asthma Allerg Res Assoc   (United Kingdom)

^g Ctr Hosp de l'Univ Laval ^*  (Canada)

^h LAVAL UNIVERSITY   (Canada)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

^k Allergologisch Diagnostisch Centrum   (Netherlands)

^l KUOPIO UNIVERSITY HOSPITAL   (Finland)

^m UNIVERSITY OF BERN   (Switzerland)

ⁿ LEICESTER ROYAL INFIRMARY   (United Kingdom)

^o TURKU UNIVERSITY HOSPITAL   (Finland)

^p Schieland Hospital   (Netherlands)

^q VANCOUVER GENERAL HOSPITAL   (Canada)

^r Allergiecentrum Amsterdam   (Netherlands)

^s MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; MOMETASONE FUROATE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION;

EID: 0345373505     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63502-8     Document Type: Article

References (19)

1. Meltzer EO. Evaluating rhinitis: clinical, rhinomanometric, and cytological assessments. J Allergy Clin Immunol 1988;82:900-8.
2. Zeiger RS. Allergic and nonallergic rhinitis: classification and pathogenesis. 1. Allergic rhinitis. Am J Rhinol 1989;3:21-47.
3. Lund V. International Consensus Report on the Diagnosis and Management of Rhinitis. Allergy 1994; 49(Suppl 19):5-34.
4. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitis subjects. J Immunol 1993; 151:3853-65.
5. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993;48:476-90.
6. Meltzer EO. Treating allergic rhinitis. Overview and update. Am J Asthma Allergy Pediatricians. 1992;6:13-7.
7. Tarlo SM, Cockcroft DW, Dolovich J, et al. Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977;59:232-6.
8. Siegel SC, Katz RM, Rachelefsky, GS et al. Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitis. J Allergy Clin Immunol 1982;69: 345-53.
9. Orgel HA, Meltzer EO, Kemp JP, et al. Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol. J Allergy Clin Immunol 1986;77:858-64.
10. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988;81:984-91.
11. Simons FER, Simons KJ. Optimum pharmacological management of chronic rhinitis. Drugs 1989;38: 313-31.
12. Mabry RL. Topical pharmacotherapy for allergic rhinitis: new agents. South Med J 1992;85:149-54.
13. Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% vs betamethasone valerate ointment 0.1 % in the treatment of psoriasis. Curr Ther Res 1988;44:790-801.
14. Medansky RS, Bressinck R, Cole GW. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. Cutis 1988;42:480-5.
15. Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991; 24:603-4.
16. Gip L, Lindberg L, Nordin P, Edwin AP. Clinical study of mometasone furoate cream 0.1% compared with hydrocortisone butyrate cream 0.1% in treatment of atopic and seborrheic dermatitis. Today's Ther Trends 1988;5: 21-34.
17. Brannan MD, Seiberling M, Cutler DL, et al. Lack of systemic activity with intranasal mometasone furoate [Abstract]. J Allergy Clin Immunol 1996;97:198.
18. Wirth MA, Nagabhushan N, Laudicina DC, et al. Disposition of radiolabeled mometasone furoate in the mouse, rat, and dog after oral and intravenous administration. ISSX Proceedings 1995; 8:275.
19. Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43: 760-75.